Dallas Cowboys offensive lineman Cooper Beebe will likely return to the lineup this week after dealing with an ankle injury.

Adan Banuelos shared an affectionate Instagram post on Tuesday, October 28, giving fans a glimpse into what’s been a ...

American pharmaceutical giant Eli Lilly and Company is investing over $1 billion (approx Rs 8,900 crore) in India to establish new contract manufacturing facilities, including a significant hub in ...

Eli Lilly & Co., the maker of the blockbuster Mounjaro diabetes drug, plans to invest more than $1 billion for contract manufacturing in India, amid 100% US tariff on the pharma sector. Eli Lilly, ...

US pharmaceutical company Eli Lilly and Company plans to invest over $1 billion in India over the next few years to set up new contract manufacturing facilities and a manufacturing and quality hub in ...

Oct 6 (Reuters) - Eli Lilly (LLY.N), opens new tab will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, ...

Mounjaro and Zepbound have helped boost the company's market cap. New data indicate these drugs do more than just help patients lose weight, contributing to potentially lowering risks to hearts and ...

Garland is tipping its hat to history — literally. The city will unveil its newest landmark, a massive 20-foot-long cowboy hat sculpture in the heart of Downtown Garland. The public is invited to ...

The Belgian e-bike company had fallen on hard times. But now ReBirth is riding to the rescue. The Belgian e-bike company had fallen on hard times. But now ReBirth is riding to the rescue. is ...

Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...

Sept. 23 (UPI) --Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ 4,000 construction workers in the greater Houston area.

Eli Lilly & Co.’s obesity pill prompted enough weight loss in a large clinical trial to be meaningful for patients and have far-reaching implications for the field, doctors said. The US drugmaker’s ...